Prescription medicine
Technetium tc 99m medronate First approved as Draximage Mdp-10
Technetium tc 99m medronate (Draximage Mdp-10) is a prescription medicine with an FDA approval on record since 1978. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: the technetium tc 99m medronate FDA label on DailyMed (effective September 8, 2025); the NDA 18035 record on Drugs@FDA; every technetium tc 99m medronate label on DailyMed.
Highlights of the record
FDA label of September 8, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageTechnetium Tc 99m medronate may be used as a bone imaging agent to delineate areas of altered osteogenesis.
Forms and strengths
- 20 mg
- 20 mg/10ml
Injection (powder) (lyophilized) for solution.
On the market
- Earliest approval on file
- November 28, 1978 Draximage Mdp-10, Jubilant; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 2 of which 0 under generic applications, 2 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- 1 since 2018 0 Class I among all firms' recalls; latest June 6, 2018
- FAERS reports
- 6 through July 30, 2026
What is technetium tc 99m medronate used for?
From the label: indications and usageTechnetium Tc 99m medronate may be used as a bone imaging agent to delineate areas of altered osteogenesis.
FDA pharmacologic class: Radioactive Diagnostic Agent.
Source: FDA drug label (Kit for the Preparation of Technetium Tc 99m Medronate), Cardinal Health 414, LLC, effective September 8, 2025 (SPL set 54608807-4df6-49ba-b065-59a19ef224c4), via openFDA; the full label on DailyMed
Is there a generic for technetium tc 99m medronate (Draximage Mdp-10)?
No generic technetium tc 99m medronate is approved (Drugs@FDA, October 8, 2026).
- 1978 earliest approval on file
- red ticks recalls
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
Has technetium tc 99m medronate been recalled?
The FDA's Enforcement Report lists 1 recall naming technetium tc 99m medronate since 2018: 0 Class I (the most serious), 1 Class II, 0 Class III; 0 still ongoing. A recall names products and lots, not every product of the medicine.
| Started | Class | Company | Reason |
|---|---|---|---|
| June 6, 2018 | Class II | Pharmalucence, Inc. | Lack of assurance of sterility: Technetium TC-99M Medronate Kit has a reported breach of sterility. |
Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026
What does the technetium tc 99m medronate label say about other medicines?
The technetium tc 99m medronate label names no other medicine on this site. The labels of 1 other medicine name technetium tc 99m medronate. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
Source: FDA drug label (Kit for the Preparation of Technetium Tc 99m Medronate), Cardinal Health 414, LLC, effective September 8, 2025 (SPL set 54608807-4df6-49ba-b065-59a19ef224c4), via openFDA; the full label on DailyMed
What do FAERS reports show for technetium tc 99m medronate?
The FDA Adverse Event Reporting System holds 6 reports that list technetium tc 99m medronate among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 0 are coded as a death and 1 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Other radioactive diagnostic agents
- the pharmacologic class, with prices and generics
- Technetium tc 99m medronate side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other